| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |